Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.

NCT04290871 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The study will start to enroll patients soon

Conditions

Coronavirus Covid-19 Infection Variant Omicron
SARS (Severe Acute Respiratory Syndrome)

Interventions

DRUG: Nitric Oxide Gas
OTHER: The delivery system will be set up anyway without study gas administration

Sponsor

Xijing Hospital